KIDS
Orthopediatrics Corp
22.80$
+1.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.8% | 73.2% | 67.9% | 84.5% | 86.7% | 65.8% | 48.8% | 43.3% | 53.0% | 51.6% | 50.1% | 50.4% | |
| 18.4% | 12.6% | 5.2% | 51.7% | 54.1% | 36.4% | 9.3% | 2.9% | 2.1% | 7.1% | 9.3% | 3.8% | |
| 18.4% | 12.6% | 5.2% | 51.7% | 54.1% | 36.4% | 26.3% | 17.8% | 27.7% | 18.3% | 14.5% | 12.0% | |
| 7.7% | 12.4% | 13.4% | 6.8% | 8.5% | 8.5% | 5.4% | 5.8% | 5.8% | 7.9% | 9.0% | 10.6% | |
| 48.4% | 47.4% | 48.5% | 25.0% | 22.9% | 19.5% | 16.3% | 18.7% | 18.3% | 24.1% | 24.7% | 26.3% | |
| 20.8% | 20.6% | 28.0% | 12.6% | 11.4% | 11.0% | 8.4% | 9.2% | 8.0% | – | – | – | |
| – | – | – | 0.0% | – | 13.5% | 21.7% | 23.5% | 20.3% | 19.1% | 19.8% | 21.5% | |
| 2.4% | 2.9% | 4.1% | 2.9% | 1.9% | 9.8% | 19.8% | 22.6% | 18.7% | 19.3% | 17.2% | 15.3% | |
| 49.8% | 63.1% | 80.5% | 42.3% | 27.1% | 26.8% | 27.7% | 26.9% | 11.5% | 14.1% | 25.1% | 31.9% | |
| 9.0% | 20.6% | 23.6% | 11.5% | 8.2% | 7.0% | 10.8% | 9.6% | 7.2% | 9.5% | 7.2% | 9.1% | |
| 0.3% | 0.3% | 0.3% | 0.1% | 0.1% | 0.1% | 3.8% | 4.2% | 0.0% | 0.0% | 0.5% | 0.0% | |
| 1.8% | 6.5% | 11.5% | 6.7% | 3.5% | 3.3% | 3.1% | 3.0% | 2.6% | 2.9% | 1.9% | 3.7% | |
| 36.7% | 42.5% | 56.8% | 30.8% | 18.9% | 13.4% | 0.3% | 0.3% | 0.2% | 2.3% | 15.4% | 19.6% | |
| 50.2% | 36.9% | 19.5% | 57.7% | 72.9% | 73.2% | 72.3% | 73.1% | 88.5% | 85.9% | 74.9% | 68.1% | |
| -177.7% | -233.2% | -254.7% | -125.2% | -102.7% | -66.2% | -49.8% | -57.7% | -41.3% | -45.1% | -49.8% | -54.1% | |
| 20.8% | 24.5% | 24.5% | 5.9% | 11.2% | 7.5% | 5.6% | 6.2% | 4.9% | 5.2% | 4.9% | 4.6% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.